Kasap, C., Izgutdina, A., Patiño-Escobar, B., Kang, A. S., Chilakapati, N., Akagi, N., Manoj, A., Johnson, H., Rashid, T., Werner, J., Barpanda, A., Geng, H., Lin, Y. T., Rampersaud, S., Gil-Alós, D., Sobh, A., Dupere-Richer, D., Aleman, A., Wicaksono, G., Kelii, K. M. K., Dalal, R., Ramos, E., Vijayanarayanan, A., Lakhani, K., Salangsang, F., Phojanakong, P., Serrano, J. A. C., Zakraoui, O., Tariq, I., Chari, A., Chung, A., Kumar, A. D., Martin, T. G., Wolf, J., Wong, S. W., Steri, V., Shanmugam, M., Boise, L. H., Kortemme, T., Parekh, S., Stieglitz, E., Licht, J. D., Karlon, W. J., Barwick, B. G., Wiita, A. P. (2025). Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells. Blood. https://doi.org/10.1182/blood.2024025536